Hoi Hannes, Grünbart Martin, de Cillia Michael, Uzel Robert, Hofer Hannah, Schlosser Lisa, Tschann Peter, Weiss Helmut, Mittermair Christof
Department of General and Visceral Surgery, St. John of God Hospital, Teaching Hospital of the Paracelsus Medical University Salzburg, Kajetanerplatz 1, 5010 Salzburg, Austria.
Department of Internal Medicine, St. John of God Hospital, Teaching Hospital of the Paracelsus Medical University Salzburg, Kajetanerplatz 1, 5010 Salzburg, Austria.
J Clin Med. 2024 Dec 23;13(24):7852. doi: 10.3390/jcm13247852.
: This study was conducted to determine whether a structured clinical pathway can help to safely implement minimally invasive surgery (MIS) as the standard approach in surgery for acute bowel obstruction (ABO). : A prospective analysis was performed on consecutive patients undergoing MIS for ABO at a single center in 2021 and 2022. Prior to the study onset, a structured treatment pathway was defined to apply MIS in all patients. The rate of success in the MIS and patient-, surgeon- and outcome-specific parameters with a focus on complication and conversion rates were analyzed. : Compared to a historical control group, the conversion rate from MIS to open surgery (OS) nearly doubled from 20.4% to 36.4% ( = 0.14). The complication rate in converted patients was 43.8% vs. 7.15% in non-converted patients ( < 0.05). : A structured clinical pathway, including technical standardization and preoperative decisional processes, can be used to implement MIS as a primary surgical treatment in ABO. This is accompanied by high conversion rates and a significant increase in postoperative complications in patients undergoing conversion. Individual decision-making concerning the surgical approach remains paramount to prevent complications and high conversion rates.
本研究旨在确定结构化临床路径是否有助于安全地将微创手术(MIS)作为急性肠梗阻(ABO)手术的标准方法实施。对2021年和2022年在单一中心接受ABO的MIS连续患者进行前瞻性分析。在研究开始前,定义了结构化治疗路径以对所有患者应用MIS。分析了MIS的成功率以及关注并发症和转化率的患者、外科医生及结局特定参数。与历史对照组相比,MIS转为开放手术(OS)的转化率从20.4%几乎翻倍至36.4%(P = 0.14)。转为开放手术患者的并发症发生率为43.8%,未转换患者为7.15%(P < 0.05)。包括技术标准化和术前决策流程在内的结构化临床路径可用于将MIS作为ABO的主要手术治疗方法实施。这伴随着高转化率以及接受转换手术患者术后并发症的显著增加。关于手术方式的个体化决策对于预防并发症和高转化率仍然至关重要。